Activation of the immune system in response to either infection or lip
opolysaccharide (LPS) produces neurophysiological, neuroendocrine and
behavioral changes. Some of the physiological consequences of LPS are
mediated by endogenous opioid peptides. The following studies were des
igned to characterize the effects of LPS in several behavioral paradig
ms, and to determine the role of opioids in mediating these effects. T
he effects of LPS on locomotor and self-care activity were assessed in
the open field test. Rats were injected with either saline or a dose
of LPS (25, 50, 100, or 1000 mu g/kg). 4 h later, the animals were pla
ced in an open field and the numbers of line crossings, rearings and g
rooming episodes were counted. LPS significantly suppressed the three
open field behaviors in a dose-related manner. The effect of LPS on se
nsitivity to pain was determined using the hot-plate and tail-flick te
sts. Administration of LPS (200 mu g/kg) increased pain sensitivity in
the hot plate test 30 min after drug administration, but produced a s
ignificant analgesic response 4 h after drug administration in both te
sts. Further characterization of LPS-induced analgesia demonstrated th
at it began about 2 h after and disappeared 30 h after the administrat
ion of LPS. Administration of naltrexone completely blocked the analge
sic effects of LPS 4 h after its administration, but had no effect on
LPS-induced suppression of activity in the open field. The effect of L
PS on body temperature was biphasic, producing hypothermia at 2 h and
hyperthermia at 8-30 h after its administration. Naltrexone had no eff
ect on the body temperature changes induced by LPS. These results sugg
est that endogenous opioids mediate the analgesic effects of LPS, but
they are involved neither in mediating LPS-induced suppression of loco
motor and self care behaviors nor in alterations of body temperature.